相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNAs as novel targets and tools in cancer therapy
Mohammed L. Abba et al.
CANCER LETTERS (2017)
Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer
Ji-Won Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors
S. Carvalho et al.
ONCOGENE (2016)
Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
Li Wang et al.
DIAGNOSTIC PATHOLOGY (2016)
Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy (vol 10, pg 583, 2015)
Evelyn Despierre et al.
TARGETED ONCOLOGY (2016)
miR-34C Disrupts the Stemness of Purified CD133+ Prostatic Cancer Stem Cells
Yuan Chen et al.
UROLOGY (2016)
Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
Cynthia Morata-Tarifa et al.
SCIENTIFIC REPORTS (2016)
MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma
Massimo Re et al.
LARYNGOSCOPE (2015)
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
Helena K. Fritz et al.
PLOS ONE (2015)
MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)
Jiali Zhang et al.
ONCOTARGET (2015)
miR-34 and p53: New Insights into a Complex Functional Relationship
Francisco Navarro et al.
PLOS ONE (2015)
Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm
Kenneth Garson et al.
REPRODUCTION (2015)
Functional Analysis of miR-34c as a Putative Tumor Suppressor in High-Grade Serous Ovarian Cancer
Zhifeng Yu et al.
BIOLOGY OF REPRODUCTION (2014)
Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
Brendan Ffrench et al.
MOLECULAR CANCER (2014)
DDB2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer
Chunhua Han et al.
MOLECULAR CANCER RESEARCH (2014)
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer
N. Panupinthu et al.
ONCOGENE (2014)
Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
Olivia A. Ebner et al.
PLOS ONE (2014)
The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells
Yang Shi et al.
PLOS ONE (2014)
Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage
Naoe Taira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Amphiregulin
Carmen Berasain et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma
Qin Xu et al.
TUMOR BIOLOGY (2014)
The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation
Zhongyan Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Ovarian cancer stem cells: Working towards the root of sternness
Rosemary Foster et al.
CANCER LETTERS (2013)
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Pengcheng Bu et al.
CELL STEM CELL (2013)
MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1
Wenxing Qin et al.
FEBS LETTERS (2013)
Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma
Xiaoxiang Chen et al.
HUMAN PATHOLOGY (2013)
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1
Yu-Ming Yeh et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
Nuzhat Ahmed et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma
Daina Skiriute et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker et al.
MOLECULAR CANCER (2013)
MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
Dengyu Chen et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
My Wintzell et al.
BMC CANCER (2012)
The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
Dongming Liang et al.
BMC CANCER (2012)
Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate
My Wintzell et al.
CANCER BIOLOGY & THERAPY (2012)
Ovarian cancer stem cell markers: Prognostic and therapeutic implications
Daniela Burgos-Ojeda et al.
CANCER LETTERS (2012)
Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
Anja Heinemann et al.
CANCER RESEARCH (2012)
Vav3-Rac1 Signaling Regulates Prostate Cancer Metastasis with Elevated Vav3 Expression Correlating with Prostate Cancer Progression and Posttreatment Recurrence
Kai-Ti Lin et al.
CANCER RESEARCH (2012)
CD44+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Erhong Meng et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Role of Farletuzumab in Epithelial Ovarian Carcinoma
Danijela Jelovac et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
Weiwei Cheng et al.
FEBS JOURNAL (2012)
MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells
Fengyan Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog
Cheng-Xiong Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
Vinod Vathipadiekal et al.
PLOS ONE (2012)
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Shannon M. McAuliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
Application of Weibull model for survival of patients with gastric cancer
Hui P. Zhu et al.
BMC GASTROENTEROLOGY (2011)
Involvement of NF-kappa B/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells
Q-Q Li et al.
CELL DEATH AND DIFFERENTIATION (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Jocelyn M. Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Ovarian Epithelial Cancer Stem Cells
Irena Conic et al.
THESCIENTIFICWORLDJOURNAL (2011)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
Cancer Stem Cells and Self-renewal
Catherine Adell O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics
Brian W. Booth et al.
EXPERIMENTAL CELL RESEARCH (2010)
miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions
Zandra Hagman et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met
Ke-Min Cai et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
Eric Pujade-Lauraine et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A protocol for immunofluorescence staining of floating neurospheres
Ryo Sasaki et al.
NEUROSCIENCE LETTERS (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
MicroRNAs and Cancer: Short RNAs Go a Long Way
Andrea Ventura et al.
CELL (2009)
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Herve Acloque et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Qing Ji et al.
PLOS ONE (2009)
Validation of HB-EGF and amphiregulin as targets for human cancer therapy
Fusanorl Yotsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells
Niels Eckstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell
Loen M. Hansford et al.
CANCER RESEARCH (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human
Nicole E. Willmarth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer
Inti Zlobec et al.
MODERN PATHOLOGY (2006)
Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells
Josefa Castillo et al.
CANCER RESEARCH (2006)
Principles of MicroRNA-target recognition
J Brennecke et al.
PLOS BIOLOGY (2005)
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
PA Vasey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Tissue microarrays: a new approach for quality control in immunohistochemistry
J Packeisen et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan
AN Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
